About Katherine Rubino

Katherine Rubino is based in Wiggin and Dana’s Boston office and is an IP and life sciences partner known for guiding companies through complex, high‑value transactions. A Doctor of Pharmacy and J.D., she brings rare scientific fluency to her work, enabling her to navigate the technical, regulatory, and commercial dimensions of life sciences deals. Katie advises pharmaceutical, vaccine, digital health, and medical device innovators on discovery collaborations, spin‑offs, divestitures, out‑licensing, capital raises, and M&A. Her ability to translate scientific detail into strategic legal outcomes makes her a sought‑after advisor across therapeutic modalities and emerging technologies.